GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,197,000 | +18.5% | 10,376 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,010,000 | -20.7% | 10,376 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $1,273,000 | +40.0% | 10,376 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $909,000 | -16.2% | 10,376 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,085,000 | -9.1% | 10,376 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,194,000 | -33.9% | 10,376 | -1.0% | 0.00% | -33.3% |
| Q2 2019 | $1,806,000 | -3.3% | 10,476 | -5.4% | 0.00% | 0.0% |
| Q1 2019 | $1,867,000 | +70.0% | 11,076 | -1.8% | 0.00% | +50.0% |
| Q4 2018 | $1,098,000 | -62.3% | 11,276 | -33.2% | 0.00% | -50.0% |
| Q3 2018 | $2,915,000 | -9.5% | 16,876 | -26.9% | 0.00% | -20.0% |
| Q2 2018 | $3,220,000 | +69.1% | 23,076 | +36.5% | 0.01% | +66.7% |
| Q1 2018 | $1,904,000 | -38.9% | 16,900 | -28.4% | 0.00% | -40.0% |
| Q4 2017 | $3,115,000 | +27.8% | 23,600 | -1.7% | 0.01% | +25.0% |
| Q3 2017 | $2,438,000 | +15.5% | 24,019 | +14.1% | 0.00% | +33.3% |
| Q2 2017 | $2,110,000 | -9.1% | 21,043 | +9.7% | 0.00% | -25.0% |
| Q1 2017 | $2,321,000 | +53.6% | 19,190 | +41.9% | 0.00% | +33.3% |
| Q4 2016 | $1,511,000 | -19.9% | 13,519 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $1,887,000 | +353.6% | 14,219 | +213.1% | 0.00% | +200.0% |
| Q2 2016 | $416,000 | +6.1% | 4,542 | -31.2% | 0.00% | 0.0% |
| Q1 2014 | $392,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|